About

NVAC will facilitate the translational efforts of NIVI by providing industry-level expertise in vaccine development and conducting the early clinical testing of our vaccine candidates.

MISSION & VISION

Facilitating translational efforts of NIVI

Bridging research, translational sciences, and development

NVAC will catalyse progress towards achieving the NIVI mission by enabling access to cutting-edge technologies and data-driven approaches to design, test, and optimise novel vaccine candidates. NVAC provides capabilities and expertise – either directly, or via external strategic partnerships – to bridge exploratory research and clinical (Phase 1 & 2, including CHIM) translational development.

objectives

Developing vaccines for a better future

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore.

ENABLE

NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships.

NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships. NIVI will require a broad portfolio of diverse vaccine platforms, as well as ensure access to a state-of-the-art ‘adjuvant toolbox’ through dedicated strategic partnerships.

Expand

OPTIMIZE

Optimize early process development and technology transfer. NVAC will ensure that quality considerations are implemented and documented from early discovery.

Optimize early process development and technology transfer. NVAC will ensure that quality considerations are implemented and documented from early discovery. Optimize early process development and technology transfer. NVAC will ensure that quality considerations are implemented and documented from early discovery.

Optimize early process development and technology transfer. NVAC will ensure that quality considerations are implemented and documented from early discovery.

Expand

OVERSEE

If NIVI’s research results in a lead vaccine candidate with promising data, a professional vaccine development team will develop a detailed proposal and budget for advanced vaccine development and clinical testing.

NVAC will then coordinate the production of GMP-certified vaccines and oversee Phase 1 and 2 clinical trials in collaboration with dedicated clinical trial partners. Once NIVI has a promising lead vaccine candidate with supporting clinical trial data, the vaccine package including intellectual property (IP) rights, preclinical/clinical data, and manufacturing know-how will be out-licensed to a commercial partner for further clinical development, large-scale manufacturing, and marketing under relevant global access and revenue sharing agreements. Any revenue will be reinvested in NIVI.

Expand

Constantly progressing

Join the team

A strong collaboration

Organization

Constantly expanding